Challenges to Clinical Trials Remain Following First FDA Cannabis-Based Drug Approval

Although a big step has been taken now that the U.S. Food and Drug Administration (FDA) has approved a cannabis-based drug for the first time, one researcher with experience in cannabis studies says how cannabidiol (CBD), the main ingredient behind the effects of such drugs, is classified in the U.S. and Canada will continue to … Continue reading Challenges to Clinical Trials Remain Following First FDA Cannabis-Based Drug Approval